Gri bio (nasdaq: gri) to participate in a virtual investor ceo connect segment

Live video webcast on wednesday, october 2 nd at 12:00 pm et la jolla, ca, sept. 25, 2024 (globe newswire) -- gri bio, inc. (nasdaq: gri) (“gri bio,” “we,” “our,” or the “company”), a biotechnology company advancing an innovative pipeline of natural killer t (nkt) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that marc hertz, phd, chief executive officer of gri bio will participate in a virtual investor ceo connect segment on october 2, 2024 at 12:00 pm et.
GRI Ratings Summary
GRI Quant Ranking